Wolfgang Miesbach: 43-Year Study Links Black Coffee to Reduced Dementia Risk
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about a recent article by Yu Zhang et al, published in JAMA:
“Black coffee, lower dementia risk ?
What a 43-year JAMA demonstrates: In a prospective study of 131,821 health professionals followed for up to 43 years, moderate intake of black caffeinated coffee (about 2–3 cups/day) and tea (1–2 cups/day) was associated with lower dementia risk and slightly better cognitive performance, whereas decaf and coffee with milk did not show the same benefit.
The authors used repeated dietary questionnaires and time-updated models to capture long-term habits and adjust for lifestyle, vascular risk factors, and overall diet quality, strengthening the robustness of the associations.
Possible explanations include caffeine’s effects on amyloid and tau pathways and adenosine signaling, polyphenols and other bioactive compounds that dampen oxidative stress and neuroinflammation, and favorable impacts on insulin sensitivity and vascular function—all of which may help preserve brain health over decades. ”
Title: Coffee and Tea Intake, Dementia Risk, and Cognitive Function
Authors: Yu Zhang, Yuxi Liu, Yanping Li, Yuhan Li, Xiao Gu, Jae H. Kang, A. Heather Eliassen, Molin Wang, Eric B. Rimm, Walter C. Willett, Frank B. Hu, Meir J. Stampfer, Dong D. Wang
Read the Full Article on JAMA
Find more posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Aug 21, 2026, 12:08Amy Allen Whitfield: Helping to Proceed Bleeding Disorders Care
-
Aug 21, 2026, 11:53Jan Terje Andersen: Harnessing Placental Biology for Therapeutic Engineering
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
-
Aug 21, 2026, 10:23Salvador Payán Pernía: Tailoring Therapy in Sickle Cell Disease – Mitapivat and the Path Toward Personalized Combination Care
-
Aug 21, 2026, 10:10Pete Stibbs: The Evolving Landscape of VTE Management
-
Aug 21, 2026, 09:58Nishant K Mishra։ When Epilepsy Meets Anticoagulation